Revenues

12 Months Ended

Aug. 31, 2025

Revenues

Revenues

10. Revenues

Revenues for the years ended August 31, 2025 and 2024 consist of the following:

	Year Ended August 31,
	2025		2024
IP Licensing	$	696,000	$	457,990
B2B		9,923		5,388
Other		-		900
Total	$	705,923	$	464,278

The Company recognized $696,000 and $457,990 in licensing revenue during the years ended August 31, 2025 and August 31, 2024, respectively. Licensing revenue consists of IP licensing fees for transfer of the DehydraTECH technology in line with definitive agreements and includes non-refundable minimum performance fees. During the years ended August 31, 2025 and August 31, 2024, the Company recognized B2B product revenues of $9,923 and $5,388, respectively, that relate to sales of our intermediate products for use by B2B customers in their products.